These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 18790443)

  • 1. Vaccine therapy and adoptive immunotherapy in hematologic malignancies.
    Avigan D
    Best Pract Res Clin Haematol; 2008 Sep; 21(3):373-4. PubMed ID: 18790443
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of immunotherapy in the treatment of patients with hematologic neoplasms].
    Rukavitsyn OA
    Vopr Onkol; 2002; 48(2):186-92. PubMed ID: 12227066
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cellular immunotherapy for hematological malignancies].
    Yasukawa M
    Rinsho Ketsueki; 2008 Oct; 49(10):1460-71. PubMed ID: 18833930
    [No Abstract]   [Full Text] [Related]  

  • 4. CAR-T cells beyond CD19, UnCAR-Ted territory.
    Leick MB; Maus MV
    Am J Hematol; 2019 May; 94(S1):S34-S41. PubMed ID: 30632631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On target: genetically modified cells show promise in targeted immunotherapy for advanced blood cancers.
    Printz C
    Cancer; 2014 Apr; 120(7):929-30. PubMed ID: 24643628
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hematologic malignancies/pediatric malignancies].
    Usui N
    Gan To Kagaku Ryoho; 2009 May; 36(5):742-3. PubMed ID: 19496282
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunotherapy for Hematologic Malignancies.
    Craddock C; Friedberg JW
    J Clin Oncol; 2021 Feb; 39(5):343-345. PubMed ID: 33434044
    [No Abstract]   [Full Text] [Related]  

  • 8. Born to survive: how cancer cells resist CAR T cell therapy.
    Lemoine J; Ruella M; Houot R
    J Hematol Oncol; 2021 Nov; 14(1):199. PubMed ID: 34809678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards immunogene therapy of hematological malignancies.
    Ivanov R; Hagenbeek A; Ebeling S
    Exp Hematol; 2006 Mar; 34(3):251-63. PubMed ID: 16543059
    [No Abstract]   [Full Text] [Related]  

  • 10. [Principal and perspective of adoptive immuno-cell therapy for hematological malignancies].
    Akatsuka Y
    Rinsho Ketsueki; 2007 Oct; 48(10):1328-38. PubMed ID: 17933117
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of hematological malignancy-associated antigens and clinical applications.
    Fujiwara H
    Rinsho Ketsueki; 2009 May; 50(5):340-51. PubMed ID: 19483393
    [No Abstract]   [Full Text] [Related]  

  • 12. Defining the Role of Donor Lymphocyte Infusion in High-Risk Hematologic Malignancies.
    Schmid C; Kuball J; Bug G
    J Clin Oncol; 2021 Feb; 39(5):397-418. PubMed ID: 33434060
    [No Abstract]   [Full Text] [Related]  

  • 13. Chimeric antigen receptor T-cell therapy for haematological malignancies.
    Selim AG; Tam CS
    Med J Aust; 2020 Nov; 213(9):404-406.e1. PubMed ID: 32951222
    [No Abstract]   [Full Text] [Related]  

  • 14. Game Changers in Treatment of Hematologic Malignancies.
    Goy A
    Oncology (Williston Park); 2019 Sep; 33(9):. PubMed ID: 31571178
    [No Abstract]   [Full Text] [Related]  

  • 15. CAR T-Cell Therapy Shows Promise in Multiple Hematologic Malignancies.
    Kahl KL
    Oncology (Williston Park); 2020 Jan; 34(1):20. PubMed ID: 32645201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular Immunotherapy for Hematologic Malignancies: Beyond Bone Marrow Transplantation.
    Cirillo M; Tan P; Sturm M; Cole C
    Biol Blood Marrow Transplant; 2018 Mar; 24(3):433-442. PubMed ID: 29102721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Modulation in Hematologic Malignancies.
    Dhodapkar MV; Dhodapkar KM
    Semin Oncol; 2015 Aug; 42(4):617-25. PubMed ID: 26320065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular immunotherapy in haematological malignancies.
    Reid CD
    Br J Haematol; 1999 Apr; 105 Suppl 1():7-10. PubMed ID: 10330926
    [No Abstract]   [Full Text] [Related]  

  • 19. [Preliminary results of transplantation of thymus originating from patients with myasthenia gravis to patients with leukemia and those with Hodgkin's disease].
    Rzepecki WM; Lukasiewicz M; Aleksandrowicz J; Szmigiel Z; Skotnicki A; Lisienicz J
    Przegl Lek; 1973; 30(6):518-20. PubMed ID: 4732446
    [No Abstract]   [Full Text] [Related]  

  • 20. The roles of stem cell memory T cells in hematological malignancies.
    Xu L; Zhang Y; Luo G; Li Y
    J Hematol Oncol; 2015 Oct; 8():113. PubMed ID: 26462561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.